Ashwagandha Capsules: Withanolide Assay, KSM-66 Alternatives, Dosage
Buyer’s snapshot
- The United States Pharmacopeia sets ashwagandha root dry extract at not less than 2.5% withanolides (USP, 2024). For stress and sleep SKUs, the working market benchmark is a root-only extract standardized to 5% withanolides verified by HPLC.
- The percentage on the spec sheet means little without the assay method. Gravimetric testing can read 2.5 to 3 times higher than HPLC on the same material, so a “2.5% withanolides” label can sit on a 1% HPLC reality.
- Plant part is part of the spec. Leaf material carries withaferin A and withanone, the compounds behind most of the current safety scrutiny. KSM-66 is the best-known root-only, 5% HPLC extract. It is not the only one.
- Market access is splitting. Denmark banned ashwagandha in food supplements in 2023, and France, Poland, and Belgium have since restricted it. The US and Australia remain open.
- Silk Foods Ceylon (SFC) encapsulates Ayurvedic botanicals under FSSC 22000 V6 at a 180-bottle MOQ, registered with Sri Lanka’s Department of Ayurveda. This post is the spec for a brand writing an ashwagandha capsule RFQ.
Most ashwagandha capsule specs that cross a procurement desk read the same way: “root extract, standardized to X% withanolides.” That number is where most buyers stop reading. It is also where the trouble starts. Two extracts can both claim 2.5% withanolides and differ in real, HPLC-verified content by a factor of three. One can be root-only. The other can carry leaf material that several regulators are now flagging. For a wellness brand putting its name on the bottle, the assay method and the plant part are the spec. The percentage is just the headline.
What withanolide percentage should an ashwagandha capsule be standardized to?
The United States Pharmacopeia sets ashwagandha root dry extract at not less than 2.5% withanolides (USP, 2024), measured as the sum of withanolide aglycones and glycosides. For a finished capsule carrying a stress, sleep, or cortisol position, the working benchmark is a root-only extract standardized to 5% withanolides by HPLC, the concentration used in most published clinical trials.
Raw ashwagandha root powder typically runs around 0.3% withanolides. That is too dilute to anchor a capsule claim, which is why finished SKUs use a concentrated extract rather than milled root. Extracts land between roughly 1.5% and 5% withanolides, and the 5% HPLC root-only grade is the one that matches the clinical literature. The math is simple once the grade is fixed: a 300 to 600 mg extract fill at 5% delivers roughly 15 to 30 mg of withanolides per day, which sits inside the range trials have used. Pick the grade first, then the fill weight, then the capsule size. For the wider category picture, see the SRV guide to sourcing functional herbs and Ayurvedic botanicals from Sri Lanka.
HPLC or gravimetric: why two “2.5% withanolides” specs are not the same
Withanolide content can be measured two ways, and the gap between them is wide. Gravimetric assay bundles withanolides with co-eluting compounds and can overstate content by 2.5 to 3 times against HPLC (peer-reviewed extraction review, *Foods*, 2023). An extract that reads 2.5% by gravimetry often reads 1 to 1.5% by HPLC. Both can be printed on a label as “2.5% withanolides,” because no rule forces a supplier to disclose the method.
This is the line that actually matters in an ashwagandha RFQ, and most briefs leave it out. Gravimetrically tested material can cost about a third of HPLC-verified material, so the incentive to test the cheap way is built in. The Ayurvedic Pharmacopoeia of India permits a gravimetric total-withanolide method, while pharmacopeial glycoside work points to HPLC. A buyer comparing two quotes on price alone, without locking the assay method, is often comparing a 1% extract to a 2.5% extract and calling them equal. The same assay discipline applies across botanicals: the moringa leaf powder spec primer walks the equivalent mesh, microbial, and marker parameters.
| Parameter | Gravimetric assay | HPLC assay |
|---|---|---|
| What it measures | Total fraction, withanolides plus co-eluting compounds | Specific withanolide molecules, separated and quantified |
| Typical reading, same material | 2.5% to 3x higher | The reference, true value |
| Worked example | Reads 2.5% | Reads 1% to 1.5% |
| Relative cost of material | Roughly one-third | Reference price |
| RFQ line to specify | Avoid as the sole basis | ”Withanolides, by HPLC” |
Source: peer-reviewed extraction review (Foods, 2023); Ayurvedic Pharmacopoeia of India method notes. Compiled by Silk Route Ventures.
Specifying root-only extract: KSM-66 and the alternatives
KSM-66 is a root-only ashwagandha extract standardized to more than 5% withanolides by HPLC, produced through an aqueous, solvent-free process and supported by more than 20 double-blind clinical trials (NutraIngredients, 2026). Root-only sourcing is not a marketing preference. Leaf material carries withaferin A and withanone, the cytotoxic compounds at the center of current regulatory review, and a root-only extract keeps them out of the bottle. The deeper trade-off sits in ashwagandha root vs leaf for capsule formulators, and the same assay-first logic drives turmeric capsule formulation, curcumin assay and piperine pairing.
KSM-66 is a branded ingredient, so a formulation built on it carries a license premium and a single-source dependency. That is a reasonable trade for a brand that wants the named clinical dossier on the label. For a brand that wants the same plant part and the same assay standard without the brand lock, a generic root-only extract standardized to 5% withanolides by HPLC is the alternative, sourced against a written spec rather than a trademark. Other branded options sit at different points: Sensoril is a root-and-leaf extract standardized to a higher withanolide-glycoside level, and Shoden is a high-glycoside extract dosed in milligrams rather than hundreds of milligrams. None of these is “better” in the abstract. They are different specs for different label claims.
Silk Route Ventures (SRV) supplies bulk ashwagandha root and encapsulates the finished SKU, so the plant part and the assay method are written into the production spec rather than assumed. For a brand that wants a custom blend (ashwagandha with black pepper for absorption framing, or paired with a second adaptogen such as triphala in an adaptogen blend), the SRV R&D and NPD team scopes the formulation before the first production run.
What ashwagandha capsule dosage should you formulate around?
Randomized trials show cortisol and stress benefits across 125 to 600 mg per day of standardized root extract, with 300 to 600 mg the most common clinical dose (*Medicine*, randomized controlled trial, 2023). High-glycoside extracts such as Shoden have shown morning-cortisol reductions at 60 to 120 mg per day. The dose target, the extract potency, and the capsule size together decide the fill.
For a 5% HPLC root extract, a single 300 mg capsule taken once or twice daily covers the mainstream clinical range, which keeps the regimen at one or two capsules and the bottle at a 60-count. The 180-bottle minimum that makes a first capsule run viable is the subject of capsule encapsulation MOQ economics for early-stage brands. A size 0 capsule holds a smaller extract-plus-excipient fill comfortably; a size 00 gives headroom for a higher single-capsule dose or an added absorption agent. Shell choice follows the buyer’s claim: an HPMC vegetable shell suits a vegan or plant-based position, while gelatin remains an option on request. Disintegration testing confirms the shell releases the fill on the timeline the label implies.
The COA parameters that gate an ashwagandha capsule SKU
Ashwagandha is a root crop and a known heavy-metal accumulator. A 2024 study by researchers at the US FDA and the NIH Office of Dietary Supplements found that extraction does not reliably reduce heavy metals and can in some cases concentrate them (*Journal of AOAC International*, 2024). That makes the certificate of analysis, not the marketing sheet, the document that decides whether a batch ships. Every batch needs a COA covering withanolides by HPLC, lead, cadmium, arsenic, mercury, and microbial load.
In Q1 2026, the SRV procurement desk saw the same request three times in a single month: brands re-specifying their ashwagandha after a contract lab flagged lead in an existing supplier’s capsule. The 2024 federal heavy-metals data did more than sit in a journal. It rewrote the next supplier-qualification checklist. The defensible position for a brand is boring and specific: root-only extract, withanolides by HPLC, a per-batch heavy-metals panel against the destination market’s action levels, and farm-level traceability on organic SKUs. That production scope sits under FSSC 22000 V6, explained for procurement teams, and the farm-side documentation is detailed in Sri Lankan herb supply-chain traceability.
Spec snapshot: ashwagandha capsule (root-only)
Plant part: root only (no leaf, no aerial parts)
Withanolides: 5% target, by HPLC (state the method on the PO)
Withaferin A: specify an upper limit
Heavy metals: per-batch lead, cadmium, arsenic, mercury against destination action levels
Microbial: total plate count, yeast and mould, *Salmonella*, *E. coli*
Capsule shell: HPMC vegetable (default) or gelatin on request
SFC capacity: 100,000 capsules per single shift; MOQ 180 bottles
Can you still sell ashwagandha capsules in the EU and UK?
Market access for ashwagandha is now split, and a formulator needs to route the SKU by destination before committing artwork. Denmark banned ashwagandha in food supplements in 2023, and France, Poland (a maximum of 10 mg of withanolides per recommended daily dose), and Belgium have since restricted it (Vitafoods Insights, 2025). An EU working group flagged the ingredient for an Article 8 safety procedure in 2024, citing potential effects on reproduction and the thyroid. The US and Australia remain open markets, and the UK Food Standards Agency has issued a call for evidence rather than a ban.
The practical read for a brand: the US and Australia are the clean launch markets for an ashwagandha capsule today, and a root-only extract with a tight withaferin A limit and a clean COA is the strongest defensible position everywhere. Building an EU-first launch on ashwagandha right now is a regulatory bet, not a sourcing decision. A multi-market brand is better served splitting the line, with ashwagandha SKUs routed to open markets and a substitute adaptogen scoped for EU shelves.
Frequently asked questions
What withanolide content should ashwagandha capsules have?
The United States Pharmacopeia sets ashwagandha root dry extract at not less than 2.5% withanolides (USP, 2024). For stress and sleep SKUs, the market benchmark is a root-only extract standardized to 5% withanolides by HPLC, which at a 300 to 600 mg daily fill delivers roughly 15 to 30 mg of withanolides, inside the clinical range.
Is KSM-66 the only root-only ashwagandha extract?
No. KSM-66 is the best-known root-only extract standardized to more than 5% withanolides by HPLC, with more than 20 clinical trials (NutraIngredients, 2026), but it is a branded ingredient with a license premium. A generic root-only extract standardized to 5% withanolides by HPLC delivers the same plant part and assay standard, sourced against a written spec.
Can I sell ashwagandha capsules in the EU?
Not freely. Denmark banned ashwagandha in supplements in 2023, and France, Poland, and Belgium have restricted it, with an EU Article 8 safety review underway (Vitafoods Insights, 2025). The US and Australia remain open, and the UK has issued a call for evidence rather than a ban. Route the SKU by destination market.
Does Silk Route Ventures manufacture private-label ashwagandha capsules at low MOQ?
Yes. Silk Foods Ceylon encapsulates ashwagandha and other Ayurvedic botanicals under FSSC 22000 V6, registered with Sri Lanka’s Department of Ayurveda, at a capsule MOQ of 180 bottles per single shift, with USDA Organic and EU Organic available on relevant SKUs. Bulk root powder ships at a 50 kg per-SKU minimum.
What capsule shell does the facility use for ashwagandha?
The default is an HPMC vegetable shell, which suits a vegan or plant-based label position, with gelatin available on request. Capsule size (typically 0 or 00) is matched to the extract fill weight and dose target, and disintegration testing confirms the shell releases the fill on the labeled timeline.
How Silk Route Ventures can help
Silk Route Ventures (SRV) manufactures nutraceutical capsules and supplies bulk Ayurvedic and functional botanicals (ashwagandha, moringa, triphala, gotukola, turmeric, gurmar) to wellness brands across the US and Australia. The Silk Foods Ceylon facility in Matale holds BRCGS and FSSC 22000 V6, with encapsulation in the FSSC 22000 V6 scope and registration with Sri Lanka’s Department of Ayurveda, plus USDA Organic and EU Organic on the relevant SKUs. Capsule MOQ is 180 bottles per single shift, bulk root MOQ is 50 kg per SKU, and samples ship door-to-door by international courier at 3 to 5 business days. For early-stage brands without a co-packer, the SRV R&D and NPD team develops custom adaptogen formulations in-house. Contact us to send an inquiry or request a sample.